Microbot Medical Inc. is awaiting a marketing clearance decision from the FDA, and the Israel Innovation Authority has provided non-dilutive grant funding.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Microbot Medical Inc. is awaiting a marketing clearance decision from the FDA, and the Israel Innovation Authority has provided non-dilutive grant funding.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Israel Innovation Authority
support and investment arm of the Israeli government
Nothing else this week.
Related events
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- FDA approval enables commercial opportunity involving CBRE Group.
- FDA clearance drives market expansion and coverage for NeurAxis, Inc.
- FDA clearance enables market entry into the U.S. for an unnamed company, which is also navigating the long-term regulatory process in Japan.
- Future Pak is seeking FDA approval for its product Mytesi to market in the U.S.
Coverage
Newest first; wire copies grouped- GlobeNewswireMicrobot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities Strengthens Balance Sheet and Continues Commercialization Readiness Plans for the LIBERTY® System as it Nears FDA Mar